Beta2-adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men

[1]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[2]  G. Jacobson,et al.  Enantioselective disposition of (R)-salmeterol and (S)-salmeterol in urine following inhaled dosing and application to doping control. , 2017, Drug testing and analysis.

[3]  M. Gillum,et al.  Towards Leanness by ‘Feeding’ a Novel Thermogenic Pathway? , 2016, Trends in Endocrinology & Metabolism.

[4]  V. Backer,et al.  Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men , 2016, Front. Pharmacol..

[5]  V. Backer,et al.  Effect of formoterol, a long-acting β2-adrenergic agonist, on muscle strength and power output, metabolism, and fatigue during maximal sprinting in men. , 2016, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  M. Scherrer-Crosbie,et al.  Relationship of brown adipose tissue perfusion and function: a study through β2-adrenoreceptor stimulation. , 2016, Journal of applied physiology.

[7]  V. Backer,et al.  Mechanisms underlying enhancements in muscle force and power output during maximal cycle ergometer exercise induced by chronic β2-adrenergic stimulation in men. , 2015, Journal of applied physiology.

[8]  R. Wood‐Baker,et al.  SULT 1A3 single-nucleotide polymorphism and the single dose pharmacokinetics of inhaled salbutamol enantiomers: are some athletes at risk of higher urine levels? , 2015, Drug testing and analysis.

[9]  V. Backer,et al.  β2‐Adrenergic stimulation enhances Ca2+ release and contractile properties of skeletal muscles, and counteracts exercise‐induced reductions in Na+–K+‐ATPase Vmax in trained men , 2014, The Journal of physiology.

[10]  V. Backer,et al.  Effect of inhaled terbutaline on substrate utilization and 300-kcal time trial performance. , 2014, Journal of applied physiology.

[11]  Alan D. Lopez,et al.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[12]  G. Jacobson,et al.  Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscle. , 2014, Drug testing and analysis.

[13]  W. D. van Marken Lichtenbelt,et al.  Brown adipose tissue volume in healthy lean south Asian adults compared with white Caucasians: a prospective, case-controlled observational study. , 2014, The lancet. Diabetes & endocrinology.

[14]  J. Greenfield,et al.  Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in men , 2013, International Journal of Obesity.

[15]  W. D. van Marken Lichtenbelt,et al.  Systemic β-Adrenergic Stimulation of Thermogenesis Is Not Accompanied by Brown Adipose Tissue Activity in Humans , 2012, Diabetes.

[16]  V. Backer,et al.  Urine and Serum Concentrations of Inhaled and Oral Terbutaline , 2012, International Journal of Sports Medicine.

[17]  J. Baker,et al.  The selectivity of β‐adrenoceptor agonists at human β1‐, β2‐ and β3‐adrenoceptors , 2010, British journal of pharmacology.

[18]  B. Waldeck,et al.  Further Studies on the Cardiomegaly Induced by β‐Adrenoceptor Agonists , 2009 .

[19]  E. Kerwin,et al.  Nebulized formoterol fumarate: Dose selection and pharmacokinetics. , 2008, Pulmonary pharmacology & therapeutics.

[20]  W. Saris,et al.  Hormone-Sensitive Lipase Serine Phosphorylation and Glycerol Exchange Across Skeletal Muscle in Lean and Obese Subjects , 2008, Diabetes.

[21]  A. Tattersfield,et al.  Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study. , 2008, British journal of clinical pharmacology.

[22]  W. Saris,et al.  HSL serine phosphorylation and glycerol exchange across skeletal muscle in lean and obese subjects: effect of beta-adrenergic stimulation , 2008 .

[23]  G. Lynch,et al.  Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. , 2008, Physiological reviews.

[24]  D. Goldspink,et al.  Relative myotoxic and haemodynamic effects of the β‐agonists fenoterol and clenbuterol measured in conscious unrestrained rats , 2006, Experimental physiology.

[25]  M. Sillence,et al.  Systemic administration of β2‐adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses , 2006, British journal of pharmacology.

[26]  M. Sillence,et al.  Chronic β-agonist administration affects cardiac function of adult but not old rats, independent of β-adrenoceptor density , 2005 .

[27]  M. Sillence,et al.  Chronic beta-agonist administration affects cardiac function of adult but not old rats, independent of beta-adrenoceptor density. , 2005, American journal of physiology. Heart and circulatory physiology.

[28]  W. Saris,et al.  Impaired β-adrenergically mediated lipolysis in skeletal muscle of obese subjects , 2004, Diabetologia.

[29]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[30]  THE EFFECT OF β 1-AND β 2-ADRENERGIC STIMULATION ON ENERGY EXPENDITURE , SUBSTRATE OXIDATION AND UCP 3 EXPRESSION IN HUMAN SKELETAL MUSCLE , 2003 .

[31]  Glen P Kenny,et al.  Effect of cold exposure on fuel utilization in humans: plasma glucose, muscle glycogen, and lipids. , 2002, Journal of applied physiology.

[32]  A. Medvedev,et al.  β-Adrenergic Activation of p38 MAP Kinase in Adipocytes , 2001, The Journal of Biological Chemistry.

[33]  W. Saris,et al.  beta(1)- and beta(2)-Adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men. , 2001, The Journal of clinical endocrinology and metabolism.

[34]  G. Cheymol.  Effects of Obesity on Pharmacokinetics , 2000 .

[35]  H. Magnussen,et al.  The effect of the enantiomers of formoterol on inherent and induced tone in guinea-pig trachea and human bronchus , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[36]  M. Palmisano,et al.  Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer. , 1999, European journal of clinical pharmacology.

[37]  Michael G. M. Derks,et al.  Biphasic effect-time courses in man after formoterol inhalation: eosinopenic and hypokalemic effects and inhibition of allergic skin reactions. , 1997, The Journal of pharmacology and experimental therapeutics.

[38]  F. Hulot,et al.  Effect of clenbuterol on productive performance, body composition and muscle biochemistry in the rabbit. , 1996, Meat science.

[39]  B. Waldeck,et al.  Steric aspects of formoterol and terbutaline: is there an adverse effect of the distomer on airway smooth muscle function? , 1996, Chirality.

[40]  A. Astrup.  The sympathetic nervous system as a target for intervention in obesity. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[41]  P. J. Randle,et al.  Metabolic fuel selection: general integration at the whole-body level , 1995, Proceedings of the Nutrition Society.

[42]  H. A. Dahl,et al.  Adrenaline stimulated glycogen breakdown in rat epitrochlearis muscles: fibre type specificity and relation to phosphorylase transformation. , 1995, Biochemistry and molecular biology international.

[43]  J. Port,et al.  Age‐Related Changes in β‐Adrenergic Neuroeffector Systems in the Human Heart , 1994, Circulation.

[44]  J. Suko,et al.  Phosphorylation of serine 2843 in ryanodine receptor-calcium release channel of skeletal muscle by cAMP-, cGMP- and CaM-dependent protein kinase. , 1993, Biochimica et biophysica acta.

[45]  C. Löfdahl,et al.  Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration. , 1989, Allergy.

[46]  Portland Press Ltd.  Palmitate inhibits liver glycolysis. Involvement of fructose 2,6-bisphosphate in the glucose/fatty acid cycle , 1988 .

[47]  E. Ferrannini.  The theoretical bases of indirect calorimetry: a review. , 1988, Metabolism: clinical and experimental.

[48]  B. Waldeck,et al.  Further studies on the cardiomegaly induced by beta-adrenoceptor agonists. , 1986, Acta pharmacologica et toxicologica.

[49]  N. Rothwell,et al.  Chronic effects of β2 agonists on body composition and protein synthesis in the rat , 1984, Bioscience reports.

[50]  T. Clausen,et al.  β2‐ADRENOCEPTORS MEDIATE THE STIMULATING EFFECT OF ADRENALINE ON ACTIVE ELECTROGENIC NA‐K‐TRANSPORT IN RAT SOLEUS MUSCLE , 1980 .

[51]  T. Clausen,et al.  Beta 2-adrenoceptors mediate the stimulating effect of adrenaline on active electrogenic Na-K-transport in rat soleus muscle. , 1980, British journal of pharmacology.

[52]  J. Kjekshus,et al.  The Effect of Free Fatty Acids on Myocardial Oxygen Consumption During Atrial Pacing and Catecholamine Infusion in Man , 1978, Circulation.

[53]  P. J. Randle.  The Interrelationships of Hormones, Fatty Acid and Glucose in the Provision of Energy , 1964, Postgraduate medical journal.

[54]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.